BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19648182)

  • 41. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
    Lu J; Zhang Q; Liang CM; Xia SJ; Zhong CP; Wang DW
    Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Development of oral DNA vaccine based on MG(7)-Ag mimotope of gastric cancer].
    Guo C; Ding J; Yu Z; Han Q; Meng F; Liu N; Fan D
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):110-3. PubMed ID: 12015027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer.
    Cui Z; Huang L
    Cancer Immunol Immunother; 2005 Dec; 54(12):1180-90. PubMed ID: 15846491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
    Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
    Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S; Zhang H; Shi H; Yu X; Kong W; Li W
    Hum Immunol; 2008; 69(4-5):250-8. PubMed ID: 18486759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
    Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Ling M; Wu TC
    J Clin Invest; 2001 Sep; 108(5):669-78. PubMed ID: 11544272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects.
    Feng KK; Zhao HY; Qiu H; Liu JX; Chen J
    Cancer Lett; 2005 Apr; 221(1):41-7. PubMed ID: 15797625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific cellular immunity and antitumor responses in C57BL/6 mice induced by DNA vaccine encoding murine AFP.
    Tian G; Yi JL; Xiong P
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):440-3. PubMed ID: 15313685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
    Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
    Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
    Johnson LE; Frye TP; Chinnasamy N; Chinnasamy D; McNeel DG
    Cancer Immunol Immunother; 2007 Jun; 56(6):885-95. PubMed ID: 17102977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
    Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
    Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models.
    Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H
    Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma.
    Xiangbing H; Yankai Z; Ming L; Yong L; Yu Z; Huiyong Z; Yingying C; Jing H; Yun X; Liang J; Rongyue C; Jingjing L
    Int Immunopharmacol; 2010 Feb; 10(2):230-8. PubMed ID: 19913113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
    Yao W; Peng Y; Du M; Luo J; Zong L
    Mol Pharm; 2013 Aug; 10(8):2904-14. PubMed ID: 23768205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
    Morozov AV; Morozov VA; Astakhova TM; Timofeev AV; Karpov VL
    Mol Biol (Mosk); 2012; 46(3):434-51. PubMed ID: 22888633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
    Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
    J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral delivery of particulate prostate cancer vaccine: in vitro and in vivo evaluation.
    Akalkotkar A; Tawde SA; Chablani L; D'Souza MJ
    J Drug Target; 2012 May; 20(4):338-46. PubMed ID: 22296308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.